Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IGC Pharma (IGC) Raw Materials (2019 - 2025)

Historic Raw Materials for Pharma (IGC) over the last 7 years, with Q3 2025 value amounting to $446000.0.

  • Pharma's Raw Materials fell 5960.14% to $446000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $446000.0, marking a year-over-year decrease of 5960.14%. This contributed to the annual value of $1.1 million for FY2025, which is 45.5% up from last year.
  • As of Q3 2025, Pharma's Raw Materials stood at $446000.0, which was down 5960.14% from $1.1 million recorded in Q2 2025.
  • Pharma's Raw Materials' 5-year high stood at $3.0 million during Q4 2022, with a 5-year trough of $446000.0 in Q3 2025.
  • In the last 5 years, Pharma's Raw Materials had a median value of $2.1 million in 2023 and averaged $1.8 million.
  • Its Raw Materials has fluctuated over the past 5 years, first skyrocketed by 91057.27% in 2021, then tumbled by 5960.14% in 2025.
  • Quarter analysis of 5 years shows Pharma's Raw Materials stood at $2.3 million in 2021, then skyrocketed by 30.5% to $3.0 million in 2022, then plummeted by 53.52% to $1.4 million in 2023, then dropped by 24.4% to $1.1 million in 2024, then crashed by 58.28% to $446000.0 in 2025.
  • Its Raw Materials was $446000.0 in Q3 2025, compared to $1.1 million in Q2 2025 and $1.1 million in Q1 2025.